OSE Financial Statements From 2010 to 2024
| OSE Stock | EUR 8.68 0.03 0.35% |
Check OSE Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OSE Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . OSE financial statements analysis is a perfect complement when working with OSE Pharma Valuation or Volatility modules.
OSE |
OSE Pharma SA Company Return On Equity Analysis
OSE Pharma's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current OSE Pharma Return On Equity | -0.15 |
Most of OSE Pharma's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OSE Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, OSE Pharma SA has a Return On Equity of -0.1482. This is 99.38% lower than that of the Biotechnology sector and 99.59% lower than that of the Health Care industry. The return on equity for all France stocks is 52.19% lower than that of the firm.
OSE Pharma SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OSE Pharma's current stock value. Our valuation model uses many indicators to compare OSE Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OSE Pharma competition to find correlations between indicators driving OSE Pharma's intrinsic value. More Info.OSE Pharma SA is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OSE Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OSE Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About OSE Pharma Financial Statements
OSE Pharma stakeholders use historical fundamental indicators, such as OSE Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although OSE Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in OSE Pharma's assets and liabilities are reflected in the revenues and expenses on OSE Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in OSE Pharma SA. Please read more on our technical analysis and fundamental analysis pages.
OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in OSE Stock
OSE Pharma financial ratios help investors to determine whether OSE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OSE with respect to the benefits of owning OSE Pharma security.